To elucidate whether cytokines induce nitric oxide synthase in vascular smooth muscle cells, we studied the effects of human recombinant interleukin-1/3 on the synthesis and release of nitric oxide in cultured rat vascular smooth muscle cells by measurement of NO 2~/ NO 3~ levels. Furthermore, we performed Northern blot analysis using subcloned polymerase chain reaction products as probes for constitutive and inducible nitric oxide synthase. Interleukin-1/3 dose dependently (1 to 20 ng/mL) stimulated NO 2~/ NO 3p roduction as a function of time. Northern blotting demonstrated the interleukin-l/3-induced expression of messenger RNA for an inducible but not for the constitutive nitric oxide synthase after 3 hours. /V G -Monomethyl L-arginine completely blocked the interleukin-l/3-induced NO 2 7NO 3~ production, the effect of which was reversed by L-arginine but not by D-arginine. Dexamethasone inhibited the interleukin-l/3-induced NO 2~/ NO 3~ production in a dose-dependent manner (10~9 to 10" 7 M) and the interleukin-l/3-inducible nitric oxide synthase messenger RNA levels. Neither a calmodulin inhibitor (W-7) nor a protein kinase C inhibitor (staurosporine) showed any effects on the induction of nitric oxide synthase transcripts or production of NO 2~/ NO 3~ stimulated by interleukin-1/3, whereas cycloheximide and actinomycin D completely inhibited the basal and stimulated NO 2~/ NO 3~ production. These data demonstrate for the first time that interleukin-1/3 induces gene expression of inducible nitric oxide synthase and its de novo protein synthesis in rat vascular smooth muscle cells, thereby leading to generation of nitric oxide via Ca 2+ /calmodulin-independent and protein kinase C-independent mechanisms. (Hypertension 1993;22:34-39) KEY WORDS • endothelium-dependent relaxing factor • nitric oxide • interleukin • muscle, smooth, vascular E ndothelium-derived relaxing factor (EDRF) or nitric oxide (NO) is synthesized from guanidino nitrogen of L-arginine by the catalytic action of NO synthases (NOS).
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To elucidate whether cytokines induce nitric oxide synthase in vascular smooth muscle cells, we studied the effects of human recombinant interleukin-1/3 on the synthesis and release of nitric oxide in cultured rat vascular smooth muscle cells by measurement of NO 2~/ NO 3~ levels. Furthermore, we performed Northern blot analysis using subcloned polymerase chain reaction products as probes for constitutive and inducible nitric oxide synthase. Interleukin-1/3 dose dependently (1 to 20 ng/mL) stimulated NO 2~/ NO 3p roduction as a function of time. Northern blotting demonstrated the interleukin-l/3-induced expression of messenger RNA for an inducible but not for the constitutive nitric oxide synthase after 3 hours. /V G -Monomethyl L-arginine completely blocked the interleukin-l/3-induced NO 2 7NO 3~ production, the effect of which was reversed by L-arginine but not by D-arginine. Dexamethasone inhibited the interleukin-l/3-induced NO 2~/ NO 3~ production in a dose-dependent manner (10~9 to 10" 7 M) and the interleukin-l/3-inducible nitric oxide synthase messenger RNA levels. Neither a calmodulin inhibitor (W-7) nor a protein kinase C inhibitor (staurosporine) showed any effects on the induction of nitric oxide synthase transcripts or production of NO 2~/ NO 3~ stimulated by interleukin-1/3, whereas cycloheximide and actinomycin D completely inhibited the basal and stimulated NO 2~/ NO 3~ production. These data demonstrate for the first time that interleukin-1/3 induces gene expression of inducible nitric oxide synthase and its de novo protein synthesis in rat vascular smooth muscle cells, thereby leading to generation of nitric oxide via Ca 2+ /calmodulin-independent and protein kinase C-independent mechanisms. (Hypertension 1993;22:34-39) KEY WORDS • endothelium-dependent relaxing factor • nitric oxide • interleukin • muscle, smooth, vascular E ndothelium-derived relaxing factor (EDRF) or nitric oxide (NO) is synthesized from guanidino nitrogen of L-arginine by the catalytic action of NO synthases (NOS). 1 At least two isoforms exist; one is constitutive NOS (cNOS) and Ca 2+ /calmodulin dependent, and the other is cytokine-inducible NOS (iNOS) and Ca 2+ /calmodulin independent. 1 cNOS is present predominantly in the brain, 2 vascular endothelium, 3 platelets, 4 and adrenal gland 5 ; iNOS exists in macrophages, 6 neutrophils, 7 and vascular smooth muscle. 8 Recently, cNOS from rat cerebellum has been cloned, which has recognition sites for nicotinamide adenine dinucleotide phosphate (NADPH), flavin adenine dinucleotide, flavin mononucleotide, and calmodulin. 9 Subsequently, iNOS from an activated mouse macrophage cell line (RAW 264.7) has been cloned, which also has binding sites for NADPH, flavin cofactors, and calmodulin, 1011 although the presumptive calmodulin binding site of mouse macrophage iNOS is only 43% identical to that of rat brain cNOS. 10 EDRF/NO synthesized from L-arginine by cNOS in vascular endothelial cells plays vital roles in the control Received August 19, 1992 ; accepted in revised form February 22, 1993 .
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of vascular tonus and prevention of thrombus formation by an anti-platelet-aggregating property.
1213 cNOS is rapidly activated by Ca 2+ -mobilizing agonists, such as bradykinin, adenosine, and endothelin-3. 1415 In contrast, activation of iNOS requires several hours after exposure to several cytokines and microbial products. It is suggested that cytokines, such as interleukin-1/3 and tumor necrosis factor-a, increase NO production by cultured vascular smooth muscle cells (VSMCs) 816 and that increased NO production by VSMCs is involved in the pathogenesis of endotoxin shock. 17 However, a detailed molecular mechanism of induction and activation of NOS in VSMCs is still obscure. Therefore, we have attempted to elucidate the cellular mechanism by which NOS is activated by interleukin-1/3 in cultured rat VSMCs and determine which NOS isoform (cNOS or iNOS) is expressed by Northern blot analysis.
Methods

Materials
Dexamethasone, L-arginine, D-arginine, and N-(6-aminohexyl)-5-chloro-l-naphthalenesulfonamide (W-7) were obtained from Sigma Chemical Co, St Louis, Mo; staurosporine from Kyowa Medex Co, Tokyo, Japan; recombinant interleukin-1/3 (lymphocyteactivating factor activity, 
Cell Culture
Rat VSMCs were prepared by the explant method and cultured in Dulbecco's modified Eagle's medium (DMEM, Flow Laboratories, Irvine, Scotland) containing 10% fetal calf serum as described. 19 The cells thus obtained showed the "hills-and-valleys" growth characteristic of cultured VSMCs, and the expression of 20-kD myosin light chain and its phosphorylation by angiotensin and vasopressin have been confirmed. 20 Subcultured VSMCs (15th to 25th passages) from a single isolate were used for studying NO 2~/ NCV production and were seeded into six-well multiwell plates (Costar Corp, Cambridge, Mass) containing DMEM with 10% fetal calf serum until confiuency. Confluent cells (5xl0 6 per well) were replaced with serum-free fresh DMEM and incubated for 12 hours. Cells were then washed with phosphate-buffered saline and incubated in 1 mL serum-free DMEM without phenol red to circumvent the interference with the absorbance in the subsequent analysis. Cell number in each experiment was corrected to 5 x 10 6 because VSMCs continue to grow beyond confluency. After completion, culture media were centrifuged at 300Qg for 10 minutes at 4°C, and the supernatant was used for analysis. NO 2 "/NO 3 " concentrations in culture media were determined essentially in the same manner as recently reported. 21 In brief, the samples were applied to a copperized cadmium reduction column to reduce NO 3t o NO 2~, which reacted with Griess reagent, using an autoanalyzer (TCI-NOX 1000, Tokyo Kasei Kogyo, Tokyo, Japan); the absorbance at 540 nm was measured.
Preparation of Probes by Polymerase Chain Reaction
The subcloned cDNA for cNOS was prepared as recently reported 22 ; its nucleotide sequence coincides with that of rat brain cNOS. Polymerase chain reaction primers for mouse iNOS were synthesized according to the oligonucleotide sequences corresponding to amino acid residues 942-948 and 1127-1134: GATCAG-GAACCTGAAGCCCC and CCTATGGGGCAAAA-AAGGGC. 11 The polymerase chain reaction products were amplified using mouse liver RNA by 40 cycles of denaturing at 94°C for 1 minute, annealing at 60°C for 1.5 minutes, and extension at 72°C for 2 minutes. The polymerase chain reaction product of expected size (577 bp) was ligated into the pGEM plasmid vector (Promega, Madison, Wis) by the TA cloning method. 23 Nucleotide sequence of the subcloned iNOS cDNA was determined by the dideoxy chain termination method 24 and coincided with that of iNOS as reported." BamHlEcoRl restriction fragments of the subcloned cDNA for iNOS and cNOS were used as probes for Northern blot analysis. 
Northern Blot Analysis
Northern blot analysis was performed essentially in the same manner as described. 25 Confluent VSMCs in 60-mm culture dishes (Falcon, Oxnard, Calif), preincubated in serum-free DMEM for 12 hours, were incubated in serum-free DMEM with or without compounds for indicated times. VSMCs from two different isolates were used for the time course and for the induction by various compounds. Total RNAs from cultured rat VSMCs were prepared by the acid guanidinium thiocyanate-phenol-chloroform method, 26 and poly (A) + RNAs were selected by oligo(dT) chromatography. Poly (A) + RNAs (10 ng) and total RNA (20 fig) were separated by formaldehyde/1.1% agarose gel electrophoresis 27 and transferred to a MagnaGraph nylon membrane (Micron Separations Inc, Westboro, Mass). The subcloned cDNAs for cNOS and iNOS were labeled with deoxycytidine 5'-[ 32 P]triphosphate by the random-primed labeling method. 28 After ultraviolet wave cross-linking, RNA immobilized on the membrane was hybridized in separate experiments with either the cDNA probe for cNOS, iNOS, or GAPDH as a probe at 42°C in the presence of 50% (cNOS and GAPDH) or 30% (iNOS) formamide. The membrane was washed five times with 0.1 x SSPE (15 mM NaCl, 1 mM NaH 2 PO 4 , and 0.1 mM EDTA/0.5% sodium dodecyl sulfate) at 50°C for cNOS and GAPDH and 37°C for iNOS for 15 minutes and was autoradiographed with an intensifying screen for 20 hours at -80°C.
Statistics
Results are expressed as mean±SEM. Statistical analysis was performed by Student's t test. A value of P<.Q5 was considered statistically significant.
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10" Fig 1, interleukin-lj3 (10 ng/mL) stimulated NO 2~/ NO 3~ production by rat VSMCs in a timedependent manner (3 to 24 hours); a significant (P<.05) increase over control was observed after 3 hours and an approximate 20-fold increase after 24 hours. Northern blot analysis using subcloned cDNA for mouse liver iNOS as a probe revealed a single band corresponding to the size of iNOS messenger RNA (mRNA) (approximately 4.4 kb) in poly (A) + RNA of rat VSMCs after stimulation with interleukin-1/3, whereas no band was detected in the absence of interleukin-1/3 (Fig 2A) . The interleukin-l/3-induced increase of iNOS mRNA was time dependent, giving an approximately 15-fold stronger signal after 10 hours of induction compared with that after 3 hours. However, Northern blotting using cDNA for rat cNOS did not show any significant band before and even after interleukin-1/3 treatment (Fig 2B) . No significant changes of GAPDH mRNA levels were observed before and after interleukin-1/3 treatment.
FlG 5. Line graph shows suppressive effect of dexamethasone on interleukin-1 ^-induced NO 2~I NOf (NOx) production by rat vascular smooth muscle cells. Confluent cells (5xlO 6 per well) were incubated with (•) or without (o) interleukin-1f3 (10 nglmL) in the presence of various doses (10~9 to 10~7 M) of dexamethasone for 12 hours. Each point is the mean of triplicate dishes; bar indicates SEM. *P<.05 vs control.
Results
As shown in
Interleukin-1/3 dose-dependently (1 to 20 ng/mL) induced increase in NO 2~/ NO 3~ production, reaching a maximum (approximately 20-fold increase over control) by 10 ng/mL; the approximate EC 50 was 7 ng/mL (Fig 3) .
L-NMMA (10~3 M) completely blocked the interleukin-l/3-induced NO 2~/ NO 3~ production, whose effect was reversed by 10-fold excess of L-arginine but not by D-arginine (Fig 4) . Dexamethasone dose-dependently (10~9 to 10" 7 M) inhibited the interleukin-l/3-induced NO 2~/ NO 3~ production by rat VSMCs, with an approximate IC 5 o of 6xl0" 9 M (Fig 5) . Both the protein synthesis inhibitor cycloheximide (1 fig/mL ) and the RNA synthesis inhibitor actinomycin D (1 fig/mL ) completely inhibited the interleukin-l/3-induced NO 2~/ NO 3 " production, whereas neither the calmodulin inhibitor W-7 (10~6 M) nor the protein kinase C inhibitor staurosporine (10~7 M) exerted any effect on the basal or interleukin-l/3-induced NO 2 7NO 3~ production by rat VSMCs (Fig 6) . Northern blot analysis using total cellular RNA of rat VSMCs (Fig 7) showed that iNOS mRNA was remarkably induced by interleukin-1/3 (10 ng/mL), which was completely blocked by dexamethasone (10~7 M); neither staurosporine (10~7 M) nor W-7 (10~6 M) exerted any effect on the interleukin-1/3-inducible iNOS mRNA levels. No cytotoxic action of these compounds on culture was observed in the concentrations used in the experiments as assessed by measurement of lactate dehydrogenase activity (data not shown).
Discussion
In sepsis syndrome, many factors, such as cytokines, leukotrienes, and prostaglandins, are involved in the development of endotoxin shock. 29 EDRF/NO, a potent vasodilator, induced by endotoxin, cytokines, or both, may also play a role in septic shock. It has been suggested that interleukin-1/3 increases intracellular cyclic GMP in rat VSMCs, possibly through activation of soluble guanylate cyclase via NO formation. 816 Both endothelial cells and macrophages release interleukin-1/3 when stimulated with endotoxin. 3031 Therefore, EDRF/NO produced by VSMCs in response to enhanced endogenous interleukin-1/3 may also be responsible for the hypotension and reduced responses to pressor agents in endotoxin shock.
The present study has clearly demonstrated that interleukin-1/3 increased NO 2~/ NO 3~ production by cultured rat VSMCs in a time-and dose-dependent manner. Because the interleukin-l/3-induced NO 2 "/NO 3 " production was inhibited by L-NMMA, a stereospecific inhibitor of NOS whose effects were reversed by L-arginine but not by D-arginine, our data strongly suggest that interleukin-1/3 stimulates NOS, which catalyzes L-arginine as a substrate to generate NO in VSMCs. It has been reported that cytokines, such as tumor necrosis factor-a and interleukin-1/3, increase accumulation of cyclic GMP in rabbit and rat VSMCs, possibly via NO production. 816 The present study thus provides evidence that interleukin-1/3 stimulates NO production in cultured rat VSMCs.
Recently, Bredt et al 9 have cloned a cDNA for cNOS from rat cerebellum, revealing recognition sites for flavin cofactors, NADPH, and calmodulin. Cloning of iNOS from activated mouse macrophage cell line (RAW 264.7) has also revealed that the deduced amino acid sequence of mouse iNOS is 51% identical to that of rat cNOS and shares binding sites for NADPH, flavin cofactors, and calmodulin. 1011 In contrast to the high homology between iNOS and cNOS in the flavin cofactors binding sites, the region of the putative calmodulin binding site in iNOS was only 43% identical to that of cNOS. The present Northern blot analysis demon-
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control CHX AMD w -7 (1 M9/ml)(1 pg/ml) (1<r strated for the first time the expression of iNOS mRNA but not cNOS mRNA in rat VSMCs after stimulation with interleukin-1/3. Our results, together with the relatively long incubation time (approximately 3 hours) required for NO production by interleukin-1/3, indicate that interleukin-1/3 induces iNOS gene to generate NO in rat VSMCs.
The present study has further shown that both cycloheximide and actinomycin D completely inhibited the interleukin-1 ^-induced NO 2~/ NO 3~ production by rat VSMCs, suggesting its transcriptional regulation of iNOS gene and de novo synthesis of iNOS. Our study revealed that staurosporine showed no effects on NO 2 7 NO 3~ production by interleukin-1/3, suggesting that iNOS activity is protein kinase C independent. This is consistent with the predicted structural feature of iNOS, with no apparent phosphorylation sites by protein kinases.
1011 Our study also showed that the calmodulin inhibitor W-7 did not suppress interleukin-1/3-induced NO 2~/ NO 3~ production either. Despite the fact that the presumptive binding site for calmodulin, although less homologous to that of cNOS, exists in iNOS, 10 our result is in good agreement with the previous observations that enzymatic activity of iNOS does not require Ca 2+ /calmodulin. 8 -32 Failure of both staurosporine and W-7 to affect the interleukin-l/3-inducible NOS transcripts by the Northern blot analysis also lends support to this contention.
Glucocorticoids have been shown to have a protective effect against endotoxin shock.
17 However, it remains unknown whether the effects of glucocorticoids are mediated via direct inhibition on cytokine synthesis, iNOS activity, or both. It has been reported that dexamethasone had only a minimal effect on interleukin-1 production by human endothelial cells stimulated by endotoxin. 30 In the present study, dexamethasone dramatically suppressed interleukin-l/3-induced NO 2~/ NO 3 " production and iNOS mRNA by rat VSMCs, suggesting its inhibitory effect on iNOS induction. This is in good agreement with the report that glucocorti- coids inhibit the expression of iNOS but not cNOS in porcine endothelial cells. 33 Taken together, these results strongly suggest that glucocorticoids directly inhibit the expression of iNOS gene rather than reduce the enzymatic activity of iNOS.
In conclusion, our study directly demonstrates for the first time that interleukin-1/3 increases Ca 2+ /calmodulin-independent EDRF/NO production by inducing iNOS gene expression in rat VSMCs and subsequent de novo synthesis of iNOS, which is dexamethasone suppressible. Thus, endotoxin-induced hypotension may be partially mediated by NO production generated by cytokine-inducible iNOS not only in macrophages but in vascular smooth muscle as well.
